UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000038929
Receipt No. R000044393
Scientific Title Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa
Date of disclosure of the study information 2019/12/20
Last modified on 2020/11/19 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa
Acronym The pathological significance of gastric lanmthanum deposition
Scientific Title Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa
Scientific Title:Acronym The pathological significance of gastric lanmthanum deposition
Region
Japan

Condition
Condition patients on hemodialysis
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the lanthanum deposition at gastric mucosa
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Analysis of the clinical significances to compare the clinical feature of the LaC-users with and without La-deposition from endoscopic biopsy specimen from gastric mucosa
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria Patients on hemodialysis taking Lanthanum Carbonate
Key exclusion criteria none
Target sample size 42

Research contact person
Name of lead principal investigator
1st name Toshihisa
Middle name
Last name Takeuchi
Organization Osaka medical college hospital
Division name Endoscopy Center
Zip code 569-8686
Address 2-7, Daigaku-machi, Takatsuki
TEL 072-683-1221
Email in2097@osaka-med.ac.jp

Public contact
Name of contact person
1st name Kazuhiro
Middle name
Last name Ota
Organization Osaka medical college
Division name Second department of internal medicine
Zip code 569-8686
Address 2-7, Daigaku-machi, Takatsuki
TEL 072-683-1221
Homepage URL
Email clash_kaz@yathoo.co.jp

Sponsor
Institute Osaka medical college
Institute
Department

Funding Source
Organization Osaka medical college
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Moriguchi Keijinkai Hospital
Address 1-47-12, Yakumohigashi-cho, Moriguchi, Osaka
Tel 06-6906-9191
Email shinya-nishida0608@live.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 12 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 42
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 04 Month 01 Day
Date of IRB
2019 Year 04 Month 05 Day
Anticipated trial start date
2019 Year 12 Month 19 Day
Last follow-up date
2019 Year 12 Month 19 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Original article was accepted.

Management information
Registered date
2019 Year 12 Month 19 Day
Last modified on
2020 Year 11 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044393